IRMD
IRADIMED CORPORATION
Price Chart
Latest Quote
$94.66
+2.30 (+2.49%)
Current Price
| Previous Close | $92.36 |
| Open | $92.41 |
| Day High | $96.00 |
| Day Low | $92.15 |
| Volume | 90,329 |
Stock Information
| Quarterly Dividend / Yield | $0.80 / 0.85% |
| Shares Outstanding | 12.78M |
| Quarterly Dividend Yield | 0.85% |
| Quarterly Dividend | $0.80 |
| Cash Equivalents | $56.37M |
| Revenue | $86.28M |
| Net Income | $23.61M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.20B |
| P/E Ratio | 51.30 |
| EPS (TTM) | $1.83 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.15B |
| Sales | $86.28M |
| Income | $23.61M |
| Book/sh | $7.71 |
| Cash/sh | $4.41 |
| Employees | 166 |
Financial Ratios
| Quick Ratio | 5.76 |
| Current Ratio | 7.13 |
| EPS Growth TTM | 24.10% |
Returns & Margins
| ROA | 16.17% |
| ROE | 25.04% |
| Gross Margin | 76.83% |
| Operating Margin | 32.93% |
| Profit Margin | 27.37% |
Ownership
| Insider Ownership | 35.20% |
| Institutional Ownership | 60.99% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 39.86 |
| P/S | 13.91 |
| P/B | 12.18 |
Analyst Data
| Recommendation | none |
| Target Price | $118.00 |
Technical Indicators
| SMA20 | $92.88 |
| SMA50 | $90.07 |
| SMA200 | $90.00 |
| RSI | 50.87 |
| ATR | 3.4205 |
| Shares Float | 8.33M |
| Short Float | 7.88% |
| Short Ratio | 4.71 |
| Volatility | 0.92 |
| Rel Volume | 0.67 |
Performance History
| Week | +3.05% |
| Month | +1.00% |
| Quarter | -7.56% |
| 6 Months | -2.95% |
| YTD | -1.29% |
| Year | +57.37% |
| 3 Years | +104.80% |
| 5 Years | +253.54% |
| 10 Years | +407.01% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $93.87 | 95,510 |
| 2026-06-24 | $94.66 | 109,500 |
| 2026-06-23 | $92.36 | 148,100 |
| 2026-06-22 | $91.69 | 95,000 |
| 2026-06-18 | $92.20 | 182,300 |
| 2026-06-17 | $91.09 | 121,900 |
| 2026-06-16 | $91.84 | 132,800 |
| 2026-06-15 | $90.79 | 158,200 |
| 2026-06-12 | $93.60 | 175,200 |
| 2026-06-11 | $96.26 | 155,600 |
| 2026-06-10 | $96.00 | 153,600 |
| 2026-06-09 | $96.42 | 154,700 |
| 2026-06-08 | $94.39 | 93,400 |
| 2026-06-05 | $93.07 | 115,800 |
| 2026-06-04 | $93.57 | 319,300 |
| 2026-06-03 | $91.12 | 112,100 |
| 2026-06-02 | $89.86 | 147,000 |
| 2026-06-01 | $92.05 | 126,600 |
| 2026-05-29 | $90.66 | 162,700 |
| 2026-05-28 | $92.19 | 75,100 |
| 2026-05-27 | $91.84 | 102,800 |
| 2026-05-26 | $92.94 | 102,300 |
About IRADIMED CORPORATION
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
đ° Latest News
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple
Simply Wall St. âĸ 2026-06-03T23:12:48Z
IRADIMED's CEO Is Selling Steadily â The Plan, Not the Stock, Is Driving It
Motley Fool âĸ 2026-06-02T12:29:44Z
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report
Insider Monkey âĸ 2026-05-27T21:18:40Z
Iradimedâs CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
Motley Fool âĸ 2026-05-26T01:02:55Z
Reaffirmed Outlook And Dividend: What Does IRMDâs Confidence Signal About Its MRI Pump Moat?
Simply Wall St. âĸ 2026-05-13T09:22:44Z
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend
Simply Wall St. âĸ 2026-05-11T12:14:18Z
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness
Simply Wall St. âĸ 2026-05-07T23:16:33Z
Discovering US Market's Undiscovered Gems in May 2026
Simply Wall St. âĸ 2026-05-07T17:33:50Z
Company News for May 4, 2026
Zacks âĸ 2026-05-04T13:33:00Z
IRadimed Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-02T12:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $19,490,000 | $16,892,000 | $15,404,027 | $12,020,742 |
| Cost Of Revenue | $19,490,000 | $16,892,000 | $15,404,027 | $12,020,742 |
| Total Revenue | $83,814,000 | $73,242,000 | $65,562,296 | $53,303,145 |
| Operating Revenue | $83,814,000 | $73,242,000 | $65,562,296 | $53,303,145 |
| Expenses | ||||
| Total Expenses | $57,667,000 | $51,277,000 | $45,526,838 | $37,675,500 |
| Other Income Expense | $205,000 | $117,000 | $-161,315 | $-28,748 |
| Net Non Operating Interest Income Expense | $2,009,000 | $2,193,000 | $1,864,113 | $581,852 |
| Operating Expense | $38,177,000 | $34,385,000 | $30,122,811 | $25,654,758 |
| Selling And Marketing Expense | $17,420,000 | $15,616,000 | $12,142,090 | $12,679,610 |
| General And Administrative Expense | $17,782,000 | $15,937,000 | $15,122,065 | $10,697,067 |
| Other Non Operating Income Expenses | - | $164,000 | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Net Interest Income | $2,009,000 | $2,193,000 | $1,864,113 | $581,852 |
| Interest Income | $2,009,000 | $2,193,000 | $1,864,113 | $581,852 |
| Normalized Income | $22,317,435 | $19,271,240 | $17,320,376 | $12,851,284 |
| Net Income From Continuing And Discontinued Operation | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Total Operating Income As Reported | $26,147,000 | $21,965,000 | $20,035,458 | $15,627,645 |
| Net Income Common Stockholders | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Net Income | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Net Income Including Noncontrolling Interests | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Net Income Continuous Operations | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Pretax Income | $28,361,000 | $24,275,000 | $21,738,256 | $16,180,749 |
| Special Income Charges | $203,000 | $-4,000 | $-12,473 | $0 |
| Interest Income Non Operating | $2,009,000 | $2,193,000 | $1,864,113 | $581,852 |
| Operating Income | $26,147,000 | $21,965,000 | $20,035,458 | $15,627,645 |
| Gross Profit | $64,324,000 | $56,350,000 | $50,158,269 | $41,282,403 |
| Per Share | ||||
| Diluted EPS | $1.75 | $1.50 | $1.35 | $1.02 |
| Basic EPS | $1.77 | $1.52 | $1.36 | $1.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $42,435 | $-9,760 | $-33,715 | $-5,951 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $27,108,000 | $22,830,000 | $20,961,953 | $16,327,066 |
| Total Unusual Items | $205,000 | $-47,000 | $-161,315 | $-28,748 |
| Total Unusual Items Excluding Goodwill | $205,000 | $-47,000 | $-161,315 | $-28,748 |
| Reconciled Depreciation | $1,166,000 | $818,000 | $765,180 | $670,673 |
| EBITDA (Bullshit earnings) | $27,313,000 | $22,783,000 | $20,800,638 | $16,298,318 |
| EBIT | $26,147,000 | $21,965,000 | $20,035,458 | $15,627,645 |
| Diluted Average Shares | $12,854,000 | $12,783,558 | $12,722,530 | $12,635,971 |
| Basic Average Shares | $12,722,000 | $12,670,216 | $12,602,948 | $12,562,856 |
| Diluted NI Availto Com Stockholders | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Tax Provision | $5,881,000 | $5,041,000 | $4,545,480 | $3,352,262 |
| Gain On Sale Of Ppe | $203,000 | $-4,000 | $-12,473 | $0 |
| Gain On Sale Of Security | $2,000 | $-43,000 | $-148,842 | $-28,748 |
| Research And Development | $2,975,000 | $2,832,000 | $2,858,656 | $2,278,081 |
| Selling General And Administration | $35,202,000 | $31,553,000 | $27,264,155 | $23,376,677 |
| Other Gand A | $17,782,000 | $15,937,000 | $15,122,065 | $10,697,067 |
Fetched: 2026-06-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $91,234,000 | $83,720,000 | $68,901,111 | $71,603,548 |
| Total Assets | $108,776,000 | $98,326,000 | $92,156,098 | $85,513,747 |
| Total Non Current Assets | $27,573,000 | $23,084,000 | $16,154,986 | $8,024,076 |
| Other Non Current Assets | $239,000 | $354,000 | $181,449 | $648,672 |
| Non Current Deferred Assets | $94,000 | $2,820,000 | $2,122,816 | $700,867 |
| Goodwill And Other Intangible Assets | $3,384,000 | $3,099,000 | $2,519,053 | $2,069,439 |
| Other Intangible Assets | $3,384,000 | $3,099,000 | $2,519,053 | $2,069,439 |
| Current Assets | $81,203,000 | $75,242,000 | $76,001,112 | $77,489,671 |
| Other Current Assets | $4,757,000 | $2,050,000 | $1,193,447 | $630,960 |
| Inventory | $11,620,000 | $10,402,000 | $12,821,194 | $5,369,233 |
| Receivables | $13,667,000 | $10,556,000 | $12,224,273 | $13,274,521 |
| Accounts Receivable | $13,667,000 | $10,556,000 | $12,224,273 | $13,274,521 |
| Allowance For Doubtful Accounts Receivable | $-191,000 | $-274,000 | $-368,835 | $-160,498 |
| Gross Accounts Receivable | $13,858,000 | $10,830,000 | $12,593,108 | $13,435,019 |
| Cash Cash Equivalents And Short Term Investments | $51,159,000 | $52,234,000 | $49,762,198 | $57,960,864 |
| Cash And Cash Equivalents | $51,159,000 | $52,234,000 | $49,762,198 | $57,960,864 |
| Non Current Deferred Taxes Assets | - | $2,820,468 | $2,122,816 | $700,867 |
| Prepaid Assets | - | - | $0 | $254,093 |
| Debt | ||||
| Total Debt | $0 | $2,000 | $2,043,043 | $2,205,286 |
| Long Term Debt And Capital Lease Obligation | $0 | $2,000 | $1,615,080 | $1,911,820 |
| Current Debt And Capital Lease Obligation | - | $153,264 | $427,963 | $293,466 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,158,000 | $11,507,000 | $20,735,934 | $11,840,760 |
| Total Non Current Liabilities Net Minority Interest | $3,978,000 | $2,995,000 | $4,408,628 | $3,287,017 |
| Non Current Deferred Liabilities | $3,978,000 | $2,993,000 | $2,793,548 | $1,375,197 |
| Current Liabilities | $10,180,000 | $8,512,000 | $16,327,306 | $8,553,743 |
| Other Current Liabilities | $313,000 | $466,000 | $250,000 | - |
| Current Deferred Liabilities | $2,871,000 | $2,260,000 | $2,570,407 | $3,373,122 |
| Payables And Accrued Expenses | $6,852,000 | $5,668,000 | $12,961,473 | $4,793,125 |
| Payables | $3,634,000 | $1,896,000 | $10,186,370 | $1,921,235 |
| Total Tax Payable | $1,814,000 | $0 | $353,282 | $121,919 |
| Income Tax Payable | $1,814,000 | $0 | $250,041 | $0 |
| Accounts Payable | $1,820,000 | $1,896,000 | $1,857,091 | $1,799,316 |
| Dividends Payable | - | $0 | $7,975,997 | $0 |
| Equity | ||||
| Common Stock Equity | $94,618,000 | $86,819,000 | $71,420,164 | $73,672,987 |
| Total Equity Gross Minority Interest | $94,618,000 | $86,819,000 | $71,420,164 | $73,672,987 |
| Stockholders Equity | $94,618,000 | $86,819,000 | $71,420,164 | $73,672,987 |
| Retained Earnings | $64,231,000 | $56,791,000 | $43,258,154 | $47,264,282 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $12,781,774 | $12,709,860 | $12,660,313 | $12,591,004 |
| Share Issued | $12,781,774 | $12,709,860 | $12,660,313 | $12,591,004 |
| Tangible Book Value | $91,234,000 | $83,720,000 | $68,901,111 | $71,603,548 |
| Invested Capital | $94,618,000 | $86,819,000 | $71,420,164 | $73,672,987 |
| Working Capital | $71,023,000 | $66,730,000 | $59,673,806 | $68,935,928 |
| Capital Lease Obligations | $0 | $2,000 | $2,043,043 | $2,205,286 |
| Total Capitalization | $94,618,000 | $86,819,000 | $71,420,164 | $73,672,987 |
| Additional Paid In Capital | $30,386,000 | $30,027,000 | $28,160,745 | $26,407,446 |
| Capital Stock | $1,000 | $1,000 | $1,265 | $1,259 |
| Common Stock | $1,000 | $1,000 | $1,265 | $1,259 |
| Non Current Deferred Revenue | $3,978,000 | $2,993,000 | $2,793,548 | $1,375,197 |
| Long Term Capital Lease Obligation | $0 | $2,000 | $1,615,080 | $1,911,820 |
| Current Deferred Revenue | $2,871,000 | $2,260,000 | $2,570,407 | $3,373,122 |
| Current Provisions | $144,000 | $118,000 | $117,463 | $94,030 |
| Current Accrued Expenses | $3,218,000 | $3,772,000 | $2,775,103 | $2,871,890 |
| Net PPE | $23,856,000 | $16,811,000 | $11,331,668 | $4,605,098 |
| Accumulated Depreciation | $-5,072,000 | $-4,595,000 | $-4,069,835 | $-3,430,330 |
| Gross PPE | $28,928,000 | $21,406,000 | $15,401,503 | $8,035,428 |
| Leases | $0 | $270,000 | $270,486 | $259,146 |
| Construction In Progress | $23,000 | $8,809,000 | $1,257,844 | $665,773 |
| Machinery Furniture Equipment | $7,865,000 | $6,073,000 | $5,576,340 | $4,905,223 |
| Buildings And Improvements | $11,526,000 | $0 | - | - |
| Land And Improvements | $9,514,000 | $6,254,000 | $6,253,790 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-555,000 | $-508,000 | $-420,730 | $-239,288 |
| Finished Goods | $1,732,000 | $1,319,000 | $1,907,729 | $411,647 |
| Work In Process | $831,000 | $568,000 | $501,191 | $369,761 |
| Raw Materials | $9,612,000 | $9,023,000 | $10,833,004 | $4,827,113 |
| Current Capital Lease Obligation | - | $153,264 | $427,963 | $293,466 |
| Other Properties | - | $154,688 | $2,043,043 | $2,205,286 |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-06-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $16,526,000 | $16,807,000 | $5,457,845 | $8,167,714 |
| Operating Activities | ||||
| Operating Cash Flow | $24,947,000 | $25,624,000 | $13,465,012 | $10,042,711 |
| Cash Flow From Continuing Operating Activities | $24,947,000 | $25,625,000 | $13,465,012 | $10,042,711 |
| Operating Gains Losses | $37,000 | $4,000 | $12,537 | $-9,766 |
| Investing Activities | ||||
| Capital Expenditure | $-8,421,000 | $-8,817,000 | $-8,007,167 | $-1,874,997 |
| Investing Cash Flow | $-8,421,000 | $-8,817,000 | $-8,007,167 | $-1,374,997 |
| Cash Flow From Continuing Investing Activities | $-8,421,000 | $-8,817,000 | $-8,007,167 | $-1,374,997 |
| Capital Expenditure Reported | $-656,000 | $-812,000 | $-566,657 | $-1,051,978 |
| Financing Activities | ||||
| Financing Cash Flow | $-17,601,000 | $-14,336,000 | $-13,656,511 | $-12,706,400 |
| Cash Flow From Continuing Financing Activities | $-17,601,000 | $-14,336,000 | $-13,656,511 | $-12,706,400 |
| Net Other Financing Charges | $-2,561,000 | $-688,000 | $-610,348 | $-293,981 |
| Cash Dividends Paid | $-15,040,000 | $-13,677,000 | $-13,222,907 | $-12,559,127 |
| Common Stock Dividend Paid | $-15,040,000 | $-13,677,000 | $-13,222,907 | $-12,559,127 |
| Other | ||||
| Income Tax Paid Supplemental Data | $3,923,000 | $6,512,000 | $5,351,708 | $1,711,500 |
| End Cash Position | $51,159,000 | $52,234,000 | $49,762,198 | $57,960,864 |
| Beginning Cash Position | $52,234,000 | $49,762,000 | $57,960,864 | $61,999,550 |
| Changes In Cash | $-1,075,000 | $2,472,000 | $-8,198,666 | $-4,038,686 |
| Proceeds From Stock Option Exercised | $0 | $29,000 | $176,744 | $146,708 |
| Net PPE Purchase And Sale | $-7,765,000 | $-8,005,000 | $-7,440,510 | $-823,019 |
| Purchase Of PPE | $-7,765,000 | $-8,005,000 | $-7,440,510 | $-823,019 |
| Change In Working Capital | $-4,345,000 | $3,750,000 | $-5,910,262 | $-5,056,390 |
| Change In Other Working Capital | $1,622,000 | $-110,000 | $639,069 | $515,726 |
| Change In Other Current Liabilities | $-150,000 | $-100,000 | $250,000 | $-146,435 |
| Change In Other Current Assets | $-40,000 | $-17,000 | $467,223 | $-398,224 |
| Change In Payables And Accrued Expense | $1,334,000 | $195,000 | $-331,901 | $1,163,906 |
| Change In Accrued Expense | $-554,000 | $997,000 | $-96,787 | $57,330 |
| Change In Payable | $1,888,000 | $-802,000 | $-235,114 | $1,106,576 |
| Change In Account Payable | $-76,000 | $-862,000 | $-216,436 | $1,124,972 |
| Change In Tax Payable | $1,964,000 | $60,000 | $-18,678 | $-18,396 |
| Change In Income Tax Payable | $1,964,000 | $60,000 | $-18,678 | $-18,396 |
| Change In Prepaid Assets | $-2,707,000 | $-1,106,000 | $-308,394 | $3,358,281 |
| Change In Inventory | $-1,377,000 | $3,126,000 | $-7,468,170 | $-1,308,956 |
| Change In Receivables | $-3,027,000 | $1,762,000 | $841,911 | $-8,240,688 |
| Changes In Account Receivables | $-3,027,000 | $1,762,000 | $841,911 | $-8,240,688 |
| Stock Based Compensation | $2,919,000 | $2,524,000 | $2,186,909 | $1,394,106 |
| Provisionand Write Offof Assets | $-37,000 | $-7,000 | $389,780 | $158,504 |
| Deferred Tax | $2,727,000 | $-698,000 | $-1,171,908 | $57,097 |
| Deferred Income Tax | $2,727,000 | $-698,000 | $-1,171,908 | $57,097 |
| Depreciation Amortization Depletion | $1,166,000 | $818,000 | $765,180 | $670,673 |
| Depreciation And Amortization | $1,166,000 | $818,000 | $765,180 | $670,673 |
| Amortization Cash Flow | $370,000 | $232,000 | $117,047 | $101,122 |
| Amortization Of Intangibles | $370,000 | $232,000 | $117,047 | $101,122 |
| Depreciation | $796,000 | $586,000 | $648,133 | $569,551 |
| Gain Loss On Sale Of PPE | $37,000 | $4,000 | $12,537 | $-1,741 |
| Net Income From Continuing Operations | $22,480,000 | $19,234,000 | $17,192,776 | $12,828,487 |
| Other Non Cash Items | - | $-1,000 | - | - |
| Net Investment Purchase And Sale | - | - | $0 | $500,000 |
| Sale Of Investment | - | - | $0 | $500,000 |
| Gain Loss On Investment Securities | - | - | - | $-8,025 |
Fetched: 2026-06-25